-
Mashup Score: 9
Discussing GI (Gastrointestinal) Cancer ASCO 2023 Highlights, focusing on practice-changing studies with Dr. Muhammad Shaalan Beg, Co-Leader Gastrointestinal Oncology, Adjunct Associate Professor of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center. Covering three important studies:
Source: oncbrothers.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 2GI ASCO 2023 Highlights with Dr. Mark Lewis – ONC Brothers - 1 year(s) ago
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Liposomal Irinotecan Regimen Pushes Toward Frontline Treatment in Metastatic Pancreatic Cancer - 4 year(s) ago
Dae Won Kim, MD, discusses the NAPOLI-1 and NAPOLI-3 trials in metastatic pancreatic cancer, as well as the role of PARP inhibitors and remaining challenges in the space.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Liposomal Irinotecan Regimen Pushes Toward Frontline Treatment in Metastatic Pancreatic Cancer - 4 year(s) ago
Dae Won Kim, MD, discusses the NAPOLI-1 and NAPOLI-3 trials in metastatic pancreatic cancer, as well as the role of PARP inhibitors and remaining challenges in the space.
Source: OncLiveCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
GI Cancer Highlights from #ASCO23 w/@ShaalanBeg - #PROSPECT- #NORPACT1- #NAPOLI3- #IMBrave050 Full Discussion: - https://t.co/bw9Q34T2o7- Also on “Oncology Brothers” podcast #gism @ASCO #OncTwitter #MedTwitter @HemOncFellows @TargetedOnc #MedEd @OncoAlert #crcsm https://t.co/pROcd6Sd8P